FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3864211000001105: Neomycin 0.25% / Gramicidin 0.025% ointment (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
15099101000001114 Neomycin 0.25% / Gramicidin 0.025% ointment (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
15099201000001119 Neomycin 0.25% / Gramicidin 0.025% ointment en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin 0.25% / Gramicidin 0.025% ointment Is a Neomycin + Gramicidin true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has active ingredient Gramicidin false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Is a Gramicidin + Neomycin false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Is a Product containing gramicidin and neomycin false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Neomycin true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has specific active ingredient Gramicidin true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has active ingredient Neomycin false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has basis of strength substance Neomycin false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Is a True Neomycin 0.25% / Gramicidin 0.025% ointment Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment 25 gram Is pack of False Neomycin 0.25% / Gramicidin 0.025% ointment Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment 25 gram Has VMP True Neomycin 0.25% / Gramicidin 0.025% ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start